Hypomethylating agents+venetoclax induction therapy in acute myeloid leukemia unfit for intensive chemotherapy - novel avenues for lesser venetoclax duration and patients with baseline infections from a developing country

Both elderly acute myeloid leukemia (AML) patients and those with baseline infections, when treated with intensive chemotherapy, are associated with high induction mortality. We report 24 patients (16-newly-diagnosed, 8-relapsed/refractory) with AML deemed unfit for intensive chemotherapy (by virtue...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Am J Blood Res
Asıl Yazarlar: Mirgh, Sumeet, Sharma, Archana, Shaikh, Mohammad Rizwan Mohammad Anwar, Kadian, Kirti, Agrawal, Narendra, Khushoo, Vishvdeep, Mehta, Pallavi, Ahmed, Rayaz, Bhurani, Dinesh
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: e-Century Publishing Corporation 2021
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8303019/
https://ncbi.nlm.nih.gov/pubmed/34322294
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller